Les membres / EUROFINS AMATSIGROUP
Activité principale :Prestataire de services spécialisé dans les études de R&D sur le médicament à usage humain et vétérinaire.
Fiche de présentation
Eurofins Amatsigroup is a leading international Contract Development and Manufacturing Organization (CDMO) based in Europe. Our company focuses on drug product development for chemical/biological entities and drug substance development for biologics.
We support small and major biopharmaceutical companies in an innovative way to help them achieving their (pre)clinical milestones timely.
Our solid track record in developing and manufacturing New Biological Entities (NBE)/New Chemical Entities (NCE) is one of our strongest asset.
We are experts in breakthrough technologies for highly potent compounds, poorly soluble drugs, lyophilisation processes and specific therapeutic areas (immunotherapies, orphan drugs, pediatric dosage forms…). Our facilities are perfectly designed for small clinical and/or commercial batches either for sterile or non-sterile dosage forms.
Involved in the earliest steps, our highly-qualified project management team will propose a complete drug development strategy in compliance with regulations.
Frequent communication through one single point of contact, flexibility, troubleshooting mindset, customized solutions, will help our clients to speed up their drug development process.
Our goal is to build a sustainable partnership with our customers to support their drug development pathway. Eurofins Amatsigroup: your CDMO partner for full drug development on innovative molecules.
Produits et services :
- Preclinical and early clinical development
- Clinical and small scale manufacturing (GMP)
- Clinical trial material (packaging & logistics)
- Global project management ǀ CMC - RA